Investors

Investors image

News

Apr.02, 2026 Release
Shionogi Completes Acquisition of All Rights to RADICAVA (edaravone)
Apr.01, 2026 Release
GSK, Pfizer and Shionogi complete changes to ViiV Healthcare shareholding
Apr.01, 2026 Release
SHIONOGI Group’s Efforts to Address AMR Highly Rated -Ranked No. 2 Among Global R&D-Based Pharmaceutical Companies in the Antimicrobial Resistance Benchmark 2026-
Mar.27, 2026 Release
Notice Regarding Bridge Loan Financing in Connection with an Additional Investment in ViiV Healthcare Ltd
Mar.24, 2026 Release
Notice Regarding the Consolidation of Shionogi‑Apnimed Sleep Science, LLC as a Subsidiary of Shionogi
  • Latest IR Information

    ・Financial Results / Supplement

    　- Presentation material

    　- Transcript

    more
  • IR Library

    ・Financial Results / Supplement

    ・Presentation materials

    ・Annual Report / Integrated Report / EHS Report

    ・Corporate Governance Report

    ・Pipeline

    ・Fact Book

    more
  • Management Policy

    ・Philosophy

    ・Business Plan

    ・Corporate Governance

    ・Disclosure Policy

    ・Business Risks

    more
  • Shareholder Information

    ・Information on Shares

    ・General Meeting of Shareholders

    ・Analyst Coverage

    ・Bonds & Ratings

    more
  • Individual Investors

    ・Pharmaceutical Business

    ・Shionogi's Strength

    ・Business Strategy

    ・Business Activities, etc.

     

    more
  • Sustainability

    View the Shionogi's approach to sustainable growth

    more
  • Financial Highlights

    Financial highlights for the last five years

    more
  • IR Calendar

    The schedule and results of IR events in each fiscal year

     

    more